Drug Shortage Report for TEVA-BUPROPION XL
Report ID | 68572 |
Drug Identification Number | 02439654 |
Brand name | ACT BUPROPION XL |
Common or Proper name | BUPROPION XL |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | BUPROPION HYDROCHLORIDE |
Strength(s) | 150MG |
Dosage form(s) | TABLET (EXTENDED-RELEASE) |
Route of administration | ORAL |
Packaging size | 500 |
ATC code | N06AX |
ATC description | ANTIDEPRESSANTS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | |
Actual start date | 2018-12-01 |
Estimated end date | 2019-10-31 |
Actual end date | 2019-10-09 |
Shortage status | Resolved |
Updated date | 2019-10-10 |
Company comments | Allocating inventory to support regular demand. Cannot support increased demand for this molecule, as well as now delays in releases from the mfg site. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v19 | 2019-10-10 | French | Compare |
v18 | 2019-10-10 | English | Compare |
v17 | 2019-10-03 | French | Compare |
v16 | 2019-10-03 | English | Compare |
v15 | 2019-10-03 | English | Compare |
v14 | 2019-09-10 | French | Compare |
v13 | 2019-09-10 | English | Compare |
v12 | 2019-09-10 | French | Compare |
v11 | 2019-09-10 | English | Compare |
v10 | 2019-08-29 | French | Compare |
v9 | 2019-08-29 | English | Compare |
v8 | 2019-08-06 | French | Compare |
v7 | 2019-08-06 | English | Compare |
v6 | 2019-06-04 | French | Compare |
v5 | 2019-06-04 | English | Compare |
v4 | 2019-04-11 | French | Compare |
v3 | 2019-04-11 | English | Compare |
v2 | 2018-12-04 | French | Compare |
v1 | 2018-12-04 | English | Compare |
Showing 1 to 19 of 19